Life Sciences Greenhouse of Central Pennsylvania

A Venture Capital Investment Company for Life Sciences Enterprises in Central Pennsylvania

  • About Us
    • About LSGPA
    • Our Team
    • Board of Directors
  • The Funding Process
  • Resources
    • The Ecosystem
    • Applicant Support
    • Why Central PA?
  • Portfolio Companies
    • Portfolio Overview
    • Devices and Diagnostics
    • Drug Discovery
    • Other
  • News and Events
    • Press Releasees
    • Video Gallery
  • Apply Now
  • Contact Us

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay

March 1, 2021 By Admin

BETHLEHEM, Pa.–(BUSINESS WIRE)–Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™ Psychiatry Laboratory Assays by Health Canada for use in measuring drug levels in patients prescribed any of the six most common antipsychotic drugs.

    “The ability of our assays to provide results within hours means that clinicians for the first time will now have a convenient diagnostic tool to assist in the management and optimization of their patient’s therapy”

The MyCare Psychiatry Laboratory Assays are essential diagnostic tools used by psychiatrists to monitor the patient’s blood concentration level of these prescribed drugs. These assays run on chemistry analyzers already present in most clinical laboratories, and the test results are available within hours instead of days.

The approved MyCare Psychiatry Laboratory Assays provide blood drug concentration levels for clozapine, risperidone, paliperidone, aripiprazole, olanzapine, and quetiapine.

“The ability of our assays to provide results within hours means that clinicians for the first time will now have a convenient diagnostic tool to assist in the management and optimization of their patient’s therapy,” stated Sal Salamone, CEO and Founder of Saladax.

These assays are available in Canada through HLS Therapeutics Inc., the exclusive Canadian distributor of Saladax’s MyCare™ Psychiatry Laboratory Assays.

ABOUT SALADAX BIOMEDICAL, INC.

Headquartered in Bethlehem, PA, Saladax Biomedical, Inc. is a privately held company that develops, manufactures, and markets assays that provide rapid therapeutic drug levels for essential and life-saving medicines prescribed by psychiatrists and oncologists. Since 2007, Saladax’s proprietary technology has been used in clinical laboratories or point-of-care settings to assist clinicians monitor and optimize patient care. Additionally, the company collaborates with leading pharmaceutical companies to develop tests for clinical trials and companion diagnostics. For more information, visit MyCareTests.com

ABOUT HLS THERAPEUTICS, INC.

Formed in 2015, HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. HLS’s focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS’s management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages. For more information, please visit: www.hlstherapeutics.com

For more information, visit Saladax.com or MyCareTests.com.

Contacts

Saladax Biomedical, Inc.

Salvatore Salamone, Ph.D., 610-419-6731

ssalamone@saladax.com

Filed Under: News and Events

Latest News

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™ Psychiatry Laboratory Assays … Read More...

Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia

Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test is now CE marked for use on the … Read More...

THE LIFE SCIENCES GREENHOUSE OF CENTRAL PA PUT MORE THAN $1.5 MILLION INTO CENTRAL PENNSYLVANIA STARTUPS IN 2020

Harrisburg, PA ̶ January 28, 2021. THE LIFE SCIENCES GREENHOUSE OF CENTRAL PA PUT MORE THAN $1.5 MILLION INTO CENTRAL PENNSYLVANIA STARTUPS IN 2020 … Read More...

Immunomic Therapeutics and CoImmune Therapeutics Enter into Partnership to Manufacture ITI-1020, a Novel Experimental Cell Therapy for Glioblastoma

November 19, 2020 04:05 PM Eastern Standard Time ROCKVILLE, Md. & DURHAM, N.C.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a … Read More...

Saladax Biomedical launches clozapine test in the US after FDA grants market authorization

Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test in the U.S.July 08, … Read More...

Archives

  • March 2021
  • January 2021
  • November 2020
  • July 2020
  • April 2020
  • January 2020
  • September 2019
  • August 2019
  • May 2019
  • March 2019
  • February 2019
  • January 2019
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • March 2017
  • January 2017
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • January 2016
Facebook
Twitter

LSGPA
Life Sciences Greenhouse of Central Pennsylvania
225 Market Street
Suite 500
Harrisburg, PA  17101
1-717-635-2100

Strawberries
LSGPA Copyright © 2018

Copyright © 2021 · WordPress · Log in